Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 12, 2005 - Issue 3
107
Views
7
CrossRef citations to date
0
Altmetric
Original

A Swedish family with the rare Phe33Leu transthyretin mutation

, , , , &
Pages 189-192 | Published online: 06 Jul 2009
 

Abstract

Familial amyloidotic polyneuropathy (FAP) designates TTR mutations where the phenotype is dominated by a peripheral sensory-motor polyneuropathy. The most common mutation is ATTR Val30Met. FAP in association with ATTR Phe33Leu has been described previously in two American families, one of Polish–Lithuanian descent and the other of Polish–American. In this study, we report the phenotype of the ATTR Phe33Leu in a Swedish family. The proband is a 48 year-old patient from northern Sweden, whose father died with symptoms suggestive of FAP. Characteristic clinical features included polyneuropathy, carpal tunnel syndrome and asymptomatic, but echocardiographic examination diagnosed cardiomyopathy. The family history supports an early intervention with orthotopic liver transplantation in patients with FAP associated with the TTR Phe33Leu, and the patient was submitted for liver transplantation.

Abbreviations
ATTR=

variant transthyretin

DHPLC=

denaturing high performance liquid chromatography

FAP=

familial amyloidotic polyneuropathy

PCR=

polymerase chain reaction

TTR=

transthyretin

Abbreviations
ATTR=

variant transthyretin

DHPLC=

denaturing high performance liquid chromatography

FAP=

familial amyloidotic polyneuropathy

PCR=

polymerase chain reaction

TTR=

transthyretin

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.